Article info
PDFOriginal research
Real-world use of immune checkpoint inhibitors in advanced or recurrent endometrial cancer
- Correspondence to Dr Yvonne G Lin, Genentech Inc, South San Francisco, CA 94080, USA; lin-liu.yvonne{at}gene.com
Citation
Real-world use of immune checkpoint inhibitors in advanced or recurrent endometrial cancer
Publication history
- Received March 28, 2024
- Accepted June 12, 2024
- First published June 30, 2024.
Article Versions
- You are currently viewing a Previous version of this article (30 June 2024).
- View the most recent version of this article
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ.